Filing Details
- Accession Number:
- 0001209191-10-035960
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-29 13:00:00
- Reporting Period:
- 2010-06-25
- Filing Date:
- 2010-06-29
- Accepted Time:
- 2010-06-29 14:06:32
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1097136 | Senorx Inc | SENO | Surgical & Medical Instruments & Apparatus (3841) | 330787406 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1252525 | Kurt Wheeler | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2010-06-25 | 161,293 | $10.97 | 2,032,475 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2010-06-28 | 46,600 | $10.97 | 1,985,875 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Footnotes
- The shares were sold as follows: 108,744 by MPM BioVentures II-QP, L.P. ("BV II QP"), 12,000 by MPM BioVentures II, L.P. ("BV II"), 2,258 by MPM Asset Management Investors 2001 LLC ("AM 2001") and 38,291 by MPM BioVentures GmbH & Co. Parallel-Beteiligungs KG ("BV KG"). MPM Asset Management II, L.P. ("AM II GP") and MPM Asset Management II LLC ("AM II LLC") are the direct and indirect general partners of BV II QP, BV II and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Michael Steinmetz and Kurt Wheeler are the members of AM II LLC and AM 2001.
- The shares are held as follows: 1,370,297 by BV II QP, 151,216 by BV II, 28,453 by AM 2001 and 482,509 by BV KG. Each member of the group disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.
- The shares were sold as follows: 31,418 by BV II QP, 3,467 by BV II, 652 by AM 2001 and 11,063 by BV KG.
- The shares are held as follows: 1,338,879 by BV II QP, 147,749 by BV II, 27,801 by AM 2001 and 471,446 by BV KG. Each member of the group disclaims beneficial ownership of the securities except to the extent of his or its pecuniary interest therein.